增加的c-MYC表达与活跃的IGH位点重组相关:c-MYC在慢性淋巴细胞白血病中的新兴作用
Kenza Guiyedi1, Milène Parquet1, Said Aoufouchi2
1Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 7276/INSERM U1262, Université de Limoges, 87000 Limoges, France.
Cancers
|November 27, 2024
概括
该c-MYC瘤基因驱动慢性淋巴细胞白血病 (CLL) 的进展,通过促进细胞增殖和引起遗传不稳定. 针对c-MYC可能为侵袭性CLL提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 慢性淋巴细胞白血病 (CLL) 是一种异质的B细胞恶性瘤.
- 该c-MYC瘤基因在细胞周期调节和增殖中发挥着关键作用.
- 过度表达c-MYC与各种癌症中的侵略性疾病表型有关.
研究的目的:
- 审查c-MYC在慢性淋巴细胞白血病 (CLL) 中的作用.
- 阐明c-MYC过度表达如何导致CLL的遗传不稳定性和疾病进展.
- 探索c-MYC作为CLL的潜在治疗点.
主要方法:
- 在CLL中调查c-MYC的研究的文献综述.
- 对将c-MYC与遗传不稳定性联系起来的分子机制的分析.
- 检查c-MYC表达和CLL攻击性之间的关联.
主要成果:
- 在没有突变的IGHV基因的CLL病例中,c-MYC显著过度表达.
- 过度表达c-MYC会导致DNA损伤,包括双链断裂和染色体转位.
- 在CLL中,c-MYC驱动细胞增殖和基因组不稳定性.
结论:
- c-MYC在CLL中发挥着双重作用,促进了扩散和基因组不稳定性.
- c-MYC的致癌活性有助于CLL的进展和攻击性.
- 准c-MYC是一个有希望的治疗途径来管理CLL.
相关概念视频
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K


